

Find Internship Details.
Download free guides.
Get special discounts on courses.
Find top universities/colleges.
Connect with expert instructors.
Enter your email to reset your password.
For additional help, contact EasyShiksha support atย info@easyshiksha.com
Join thousands of students achieving their dreams with expert-led courses.
1M+ students are already learning โ join them today.
Join free and unlock everything on EasyShiksha.
Takes less than 3 seconds โ no password needed
Please enter a valid email address.
No password needed if you use Google above
Checking your emailโฆ
Used only for verification & updates
Minimum 8 characters • Keep it secure
Almost done โ just verify your number so we can send course updates and certificates.
Used only for verification & updates
We sent a 4-digit OTP to XXXXXXXXXX Edit
This helps us issue your certificates and updates
Incorrect OTP. Please try again.
Takes less than 10 seconds
Please select your country.
Please select your state.
Patents include treatments for multiple sclerosis, cancer and new medical implants and nano contrast agents
National, 4 June, 2021: Amrita Center for Nanoscience and Molecular Medicine at the Kochi Campus of Amrita University has bagged seven national and international patents for its inventions. All seven patents are related to the health sector. Three inventions have received American patents and four inventions have received Indian patents, said Dr. Shanti Kumar V. Nair, Director of Amrita Center for Nanoscience and Molecular Medicine and Dean of Research, Amrita Vishwa Vidyapeetham.
The first U.S. patent was granted for a medicine to treat multiple sclerosis, a disease that affects the body's nervous system. This is a comforting discovery for those suffering from Multiple Sclerosis (MS) worldwide.
The second U.S. patent is for developing the world's first multimodal nano-contrast agent that can provide improved image resolution in X-rays, MRIs, and infrared fluorescence. It is an effective and innovative discovery for both detection and treatment of cancer.
A third U.S. patent has been obtained for a nanotextile-based small-diameter blood vessel graft which lasts longer without occlusion during use. It has been successfully tested in rabbits and pigs. The next step will be testing in humans.
An Indian patent was obtained for the invention of a core-shell nanoparticle system that could deliver multiple drugs simultaneously and target them to the disease efficiently without causing toxicity. Many cancers require multiple drug administration which can otherwise be very toxic.
An Indian patent was obtained for the development of a new type of surface-nanostructured orthopaedic and dental implant which integrates very well to surrounding normal bone. It improves implant life.
The last Indian patent was obtained for the invention of a new surface-modified stent that prevents blockage of the vessel after implant. Current stents elute drugs to prevent blockage but this stent does not require any drugs.
The research behind these discoveries were led by Dr. Shanti Kumar V. Nair, Director of Amrita Center for Nanoscience and Molecular Medicine, Dr. Manzoor Koyakutty, Dr. Deepthy Menon, Dr Praveen Verma, Dr Krishnakumar Menon, Dr Gopi Mohan, Dr. Anusha Ashokan, and Dr. Vijay Harish.
Amrita Center for Nanoscience and Molecular Medicine now has a total of 21 patents, out of which 11 are international patents. Also, they have applied for a total of 83 patents.
More News Click Here
Tags :
New Courses
Opamp Projects: Design & Simulate Operational Amplifier Based Projects on Proteus & LTSpice Software
Biomedical Project: Design Digital Thermometer with Atmega32, Arduino & LM35 Temperature Sensor
Fusion 360 Learn CAD and Earn Money Online
Analog Electronic Lab Based Course on MOSFETs using MULTISIM
Discover thousands of colleges and courses, enhance skills with online courses and internships, explore career alternatives, and stay updated with the latest educational news..
Gain high-quality, filtered student leads, prominent homepage ads, top search ranking, and a separate website. Let us actively enhance your brand awareness.
Trusted by Standards & Global Compliance Frameworks
Built under internationally recognized standards for quality, information security, educational excellence and business continuity.
ISO 9001:2015 | ISO/IEC 27001:2022 | ISO 21001:2018 | ISO 22301:2019 | DPIIT Recognized Startup | MSME Registered